La Jolla, California
United States
178
2024-11-28
118
2026-03-17
These are the the leading inventors for applications assigned to AMBRX, INC.:
AMBRX, INC. based in La Jolla, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
INTERLEUKIN-2 POLYPEPTIDE CONJUGATES AND THEIR USES
#2 | 2024-10-24HUMANIZED ANTI-PROSTATE -SPECIFIC MEMBRANE ANTIGEN (PSMA) ANTIBODY DRUG CONJUGATES
#3 | 2024-07-18ANTI-CD3-FOLATE CONJUGATES AND THEIR USES
#4 | 2024-05-23 ✅ Patent 12,577,575 granted on 2026-03-17METHODS AND COMPOSITIONS FOR PROMOTING NON-NATURAL AMINO ACID-CONTAINING PROTEIN PRODUCTION
#5 | 2023-11-02 ✅ Patent 12,612,440 granted on 2026-04-28MODIFIED BOVINE G-CSF POLYPEPTIDES AND THEIR USES
#6 | 2023-10-26 ✅ Patent 12,286,462 granted on 2025-04-29Porcine G-CSF variants and their uses
#7 | 2023-09-28ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF
#8 | 2023-09-21 ✅ Patent 12,037,405 granted on 2024-07-16Anti-CD70 antibody drug conjugates
#9 | 2023-03-30ANTIBODY DRUG CONJUGATE FOR ANTI-INFLAMMATORY APPLICATIONS
#10 | 2022-12-29 ✅ Patent 12,622,944 granted on 2026-05-12COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID LINKED DOLASTATIN DERIVATIVES
#11 | 2022-08-18 ✅ Patent 11,786,578 granted on 2023-10-17Modified relaxin polypeptides and their uses
#12 | 2022-07-21 ✅ Patent 12,569,566 granted on 2026-03-10COMPOSITIONS CONTAINING, METHODS AND USES OF ANTIBODY-TLR AGONIST CONJUGATES
#13 | 2022-02-24 ✅ Patent 12,049,485 granted on 2024-07-30Interleukin-2 polypeptide conjugates and their uses
#14 | 2022-01-13INTERLEUKIN-10 POLYPEPTIDE CONJUGATES, DIMERS THEREOF, AND THEIR USES
#15 | 2021-10-14 ✅ Patent 12,377,294 granted on 2025-08-05Anti-CD3 Antibody Folate Bioconjugates and Their Uses
#16 | 2021-09-09 ✅ Patent 11,420,999 granted on 2022-08-23Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
#17 | 2021-04-15 ✅ Patent 12,404,512 granted on 2025-09-02A METHOD FOR OPTIMIZING ANTIBODY EXPRESSION
#18 | 2021-02-25 ✅ Patent 11,578,111 granted on 2023-02-14Porcine G-CSF variants and their uses
#19 | 2021-01-21 ✅ Patent 11,851,662 granted on 2023-12-26Methods and compositions for promoting non-natural amino acid-containing protein production
#20 | 2021-01-21 ✅ Patent 12,059,473 granted on 2024-08-13Humanized anti-prostate -specific membrane antigen (PSMA) antibody drug conjugates
#21 | 2020-12-17 ✅ Patent 11,773,150 granted on 2023-10-03Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors
#22 | 2020-11-19 ✅ Patent 11,439,710 granted on 2022-09-13Nucleic acids encoding modified relaxin polypeptides
#23 | 2020-11-19 ✅ Patent 11,311,605 granted on 2022-04-26Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptides
#24 | 2020-05-28 ✅ Patent 11,510,993 granted on 2022-11-29Antibody drug conjugate for anti-inflammatory applications
#25 | 2020-01-30 ✅ Patent 10,961,291 granted on 2021-03-30Modified FGF-21 polypeptides and their uses
#26 | 2019-11-07 ✅ Patent 11,459,392 granted on 2022-10-04Anti-CD70 antibody drug conjugates
#27 | 2019-08-15 ✅ Patent 10,751,391 granted on 2020-08-25Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acid
#28 | 2019-07-04BOVINE FIBROBLAST GROWTH FACTOR 21 AND KETOSIS IN DAIRY CATTLE
#29 | 2019-06-27 ✅ Patent 10,960,080 granted on 2021-03-30Pegylated porcine interferon and methods of use thereof
#30 | 2019-03-07 ✅ Patent 11,542,310 granted on 2023-01-03Modified bovine G-CSF polypeptides and their uses
#31 | 2018-11-08 ✅ Patent 11,851,488 granted on 2023-12-26Anti-CD3-folate conjugates and their uses
#32 | 2018-11-01 ✅ Patent 10,702,588 granted on 2020-07-07Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chain
#33 | 2018-10-18 ✅ Patent 10,377,805 granted on 2019-08-13Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their uses
#34 | 2018-01-11 ✅ Patent 10,954,270 granted on 2021-03-23Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
#35 | 2017-08-10 ✅ Patent 10,253,083 granted on 2019-04-09Therapeutic uses of modified relaxin polypeptides
#36 | 2017-06-29 ✅ Patent 10,550,190 granted on 2020-02-04Phosphate based linkers for intracellular delivery of drug conjugates
#37 | 2017-04-06 ✅ Patent 9,868,972 granted on 2018-01-16Hybrid suppressor tRNA for vertebrate cells
#38 | 2017-04-06 ✅ Patent 9,975,936 granted on 2018-05-22Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acids
#39 | 2017-02-09 ✅ Patent 9,962,450 granted on 2018-05-08Method of treating heart failure with modified relaxin polypeptides
#40 | 2016-02-25 ✅ Patent 9,796,754 granted on 2017-10-24Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
#41 | 2016-01-28 ✅ Patent 9,644,014 granted on 2017-05-09Modified animal erythropoietin polypeptides and their uses
#42 | 2015-12-24 ✅ Patent 10,105,447 granted on 2018-10-23Method of treating obesity in a companion animal comprising administering a modified canine leptin polypeptide
#43 | 2015-10-22Modified Insulin Polypeptides and Their Uses
#44 | 2015-10-01 ✅ Patent 9,517,273 granted on 2016-12-13Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids
#45 | 2015-06-04 ✅ Patent 10,800,856 granted on 2020-10-13Prostate-specific membrane antigen antibody drug conjugates
#46 | 2015-06-04Anti-PSMA Antibodies Conjugated to Nuclear Receptor Ligand Polypeptides
#47 | 2015-05-21 ✅ Patent 10,208,123 granted on 2019-02-19Anti-CD70 antibody drug conjugates
#48 | 2015-04-02 ✅ Patent 9,637,441 granted on 2017-05-02Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#49 | 2015-03-19Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acid Linked Dolastatin Derivatives
#50 | 2015-02-05Interleukin-3 Polypeptide Conjugates and Their Uses
#51 | 2015-02-05Interleukin-10 Polypeptide Conjugates and Their Uses
#52 | 2015-01-29Modified Adiponectin Polypeptides and Their Uses
#53 | 2015-01-15Novel Prodrug Containing Molecule Compositions and Their Uses
#54 | 2014-10-02Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
#55 | 2014-10-02Modified Human Growth Hormone Polypeptides and Their Uses
#56 | 2014-07-10 ✅ Patent 9,452,222 granted on 2016-09-27Nucleic acids encoding modified relaxin polypeptides
#57 | 2014-04-10 ✅ Patent 9,586,988 granted on 2017-03-07Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#58 | 2014-02-13Suppressor tRNA Transcription in Vertebrate Cells
#59 | 2014-01-09 ✅ Patent 9,156,899 granted on 2015-10-13Modified animal erythropoietin polypeptides and their uses
#60 | 2013-12-05 ✅ Patent 10,428,333 granted on 2019-10-01Non-natural amino acid replication-dependent microorganisms and vaccines
#61 | 2013-10-24 ✅ Patent 9,121,025 granted on 2015-09-01Non-natural amino acid replication-dependent microorganisms and vaccines
#62 | 2013-09-12 ✅ Patent 9,567,386 granted on 2017-02-14Therapeutic uses of modified relaxin polypeptides
#63 | 2013-09-12Biosynthetic Polypeptide Fusion Inhibitors
#64 | 2013-06-13 ✅ Patent 9,079,971 granted on 2015-07-14Modified FGF-21 polypeptides comprising non-naturally occurring amino acids
#65 | 2013-01-31 ✅ Patent 8,846,876 granted on 2014-09-30Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#66 | 2013-01-17 ✅ Patent 8,569,233 granted on 2013-10-29Modified animal erythropoietin polypeptides and their uses
#67 | 2012-12-13 ✅ Patent 8,865,658 granted on 2014-10-21Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#68 | 2012-11-08MODIFIED PORCINE SOMATOTROPIN POLYPEPTIDES AND THEIR USES
#69 | 2012-11-08MODIFIED BOVINE SOMATOTROPIN POLYPEPTIDES AND THEIR USES
#70 | 2012-08-02 ✅ Patent 8,329,869 granted on 2012-12-11Modified interferon beta polypeptides and their uses
#71 | 2012-07-26 ✅ Patent 9,074,010 granted on 2015-07-07Modified human plasma polypeptide or Fc scaffolds and their uses
#72 | 2012-06-14 ✅ Patent 9,938,333 granted on 2018-04-10Modified leptin polypeptides and their uses
#73 | 2012-06-07 ✅ Patent 8,232,371 granted on 2012-07-31Modified human interferon polypeptides and their uses
#74 | 2012-06-07Biosynthetic Polypeptide Fusion Inhibitors
#75 | 2012-02-23 ✅ Patent 8,735,539 granted on 2014-05-27Relaxin polypeptides comprising non-naturally encoded amino acids
#76 | 2012-02-16Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
#77 | 2011-12-01Modified Human Growth Hormone
#78 | 2011-11-24 ✅ Patent 8,476,411 granted on 2013-07-02Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#79 | 2011-11-03 ✅ Patent 9,574,048 granted on 2017-02-21Polymer derivatives
#80 | 2011-08-25Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
#81 | 2011-08-11Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid
#82 | 2011-08-11 ✅ Patent 9,121,024 granted on 2015-09-01Non-natural amino acid replication-dependent microorganisms and vaccines
#83 | 2011-07-21Modified Human Apolipoprotein A-1 and Their Uses
#84 | 2011-07-14 ✅ Patent 8,383,365 granted on 2013-02-26Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives
#85 | 2011-06-16 ✅ Patent 9,488,660 granted on 2016-11-08Methods and compositions comprising non-natural amino acids
#86 | 2011-05-26 ✅ Patent 8,791,231 granted on 2014-07-29Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#87 | 2011-05-19 ✅ Patent 8,859,802 granted on 2014-10-14Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#88 | 2011-05-19 ✅ Patent 8,809,511 granted on 2014-08-19Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#89 | 2011-05-19 ✅ Patent 8,071,809 granted on 2011-12-06Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
#90 | 2011-01-20Modified FGF-23 Polypeptides and Their Uses
#91 | 2010-11-25 ✅ Patent 8,946,148 granted on 2015-02-03Modified insulin polypeptides and their uses
#92 | 2010-08-26 ✅ Patent 7,820,766 granted on 2010-10-26Branched acetylene-containing poly(alkylene oxides, oxyethylated polyols or olefinic alcohols)
#93 | 2010-07-22 ✅ Patent 7,829,310 granted on 2010-11-09Compositions of aminoacyl-tRNA synthetase and uses thereof
#94 | 2010-07-08 ✅ Patent 7,846,689 granted on 2010-12-07Compositions of aminoacyl-tRNA synthetase and uses thereof
#95 | 2010-07-08 ✅ Patent 7,838,265 granted on 2010-11-23Compositions of aminoacyl-tRNA synthetase and uses thereof
#96 | 2010-07-08 ✅ Patent 7,883,866 granted on 2011-02-08Compositions of aminoacyl-tRNA synthetase and uses thereof
#97 | 2010-07-01 ✅ Patent 7,858,344 granted on 2010-12-28Compositions of aminoacyl-tRNA synthetase and uses thereof
#98 | 2010-06-24 ✅ Patent 8,618,257 granted on 2013-12-31Modified human plasma polypeptide or Fc scaffolds and their uses
#99 | 2010-06-24 ✅ Patent 9,133,495 granted on 2015-09-15Hybrid suppressor tRNA for vertebrate cells
#100 | 2010-06-24 ✅ Patent 8,420,792 granted on 2013-04-16Suppressor tRNA transcription in vertebrate cells
Also check out AMBRX, INC.'s (La Jolla, United States) applicant profile with 52 patent applications submitted.
4913 ⎘